about
The role of stem cell therapy in multiple sclerosis: An overview of the current status of the clinical studiesCurbing Inflammation in Multiple Sclerosis and Endometriosis: Should Mast Cells Be Targeted?Mesenchymal stem cells engineered to express selectin ligands and IL-10 exert enhanced therapeutic efficacy in murine experimental autoimmune encephalomyelitis.Placental Stromal Cell Therapy for Experimental Autoimmune Encephalomyelitis: The Role of Route of Cell Delivery.Myelin repair and functional recovery mediated by neural cell transplantation in a mouse model of multiple sclerosis.Sox10-MCS5 enhancer dynamically tracks human oligodendrocyte progenitor fate.CD133/CD140a-based isolation of distinct human multipotent neural progenitor cells and oligodendrocyte progenitor cellsIntranasal Delivery of Neural Stem Cells: A CNS-specific, Non-invasive Cell-based Therapy for Experimental Autoimmune Encephalomyelitis.Devices for cell transplantation into the central nervous system: Design considerations and emerging technologies.Disease modification in multiple sclerosis: an update.Strategies for myelin regeneration: lessons learned from development.Concise Review: Prospects of Bone Marrow Mononuclear Cells and Mesenchymal Stem Cells for Treating Status Epilepticus and Chronic Epilepsy.Models for Studying Myelination, Demyelination and Remyelination.LINGO-1-Fc-Transduced Neural Stem Cells Are Effective Therapy for Chronic Stage Experimental Autoimmune Encephalomyelitis.Time limited immunomodulatory functions of transplanted neural precursor cells.N-Phenylquinazolin-2-amine Yhhu4952 as a novel promotor for oligodendrocyte differentiation and myelination
P2860
Q26750597-0CFAAA8E-18C5-4C12-828C-3F5A4AA97946Q26778470-EF2FCBF3-2F3B-4A1E-8C48-372799EBD27AQ30690412-E194E98C-3398-44D3-B220-295FE72D53ABQ33722575-BC539965-7103-49F3-B3FF-DAA6310A7DB4Q33981047-FC183890-C2A0-4B92-96F4-56AAD3FA63BEQ34626274-2C41ED11-EB7F-4A42-8150-F38389639FBDQ37025715-A2410525-6C4F-4684-81AF-6A43FF95973CQ37304992-AE0FD983-D612-411F-965A-3D6E6ABC0D86Q38105080-43575CD8-E3C1-4AF4-A14D-97AEB390D836Q38150823-2C8532E2-8540-4B06-A038-51DAE93E17AEQ38249189-579196E1-9E06-45E4-9C04-94D1D9912E05Q38410150-75552F71-7003-46D9-BE29-16663495A1C4Q39325813-F9762E85-1D5F-48C5-A0F6-8DC9CB328B6DQ45855575-2A5C6D0E-55E1-43AA-87DF-068EED97587EQ48366060-64DCFD40-A6E3-424B-914D-F9413CFE4586Q58720052-1BEE9CCA-1B8B-4B90-BEF1-9DAB139D1E43
P2860
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Cell therapy for multiple sclerosis.
@ast
Cell therapy for multiple sclerosis.
@en
type
label
Cell therapy for multiple sclerosis.
@ast
Cell therapy for multiple sclerosis.
@en
prefLabel
Cell therapy for multiple sclerosis.
@ast
Cell therapy for multiple sclerosis.
@en
P2860
P1433
P1476
Cell therapy for multiple sclerosis.
@en
P2093
Tamir Ben-Hur
P2860
P2888
P304
P356
10.1007/S13311-011-0073-X
P577
2011-10-01T00:00:00Z